These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 934411

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 27. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.
    Waldmann TA, Strober W, Mogielnicki RP.
    J Clin Invest; 1972 Aug; 51(8):2162-74. PubMed ID: 5054468
    [Abstract] [Full Text] [Related]

  • 28. Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.
    Peters JH, Gotch FA, Keen M, Berridge BJ, Chao WR.
    Trans Am Soc Artif Intern Organs; 1974 Aug; 20 B():417-23. PubMed ID: 4450293
    [No Abstract] [Full Text] [Related]

  • 29. [Excretion of K-+ and h-+ in the normal and uremic patient].
    Palma Alvarez A, Aznar Reig A.
    Rev Clin Esp; 1974 Dec 31; 135(6):569-71. PubMed ID: 4460100
    [No Abstract] [Full Text] [Related]

  • 30. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G, Chu J, Liu X, Yuan Z.
    Clin Chim Acta; 2004 Dec 31; 350(1-2):89-98. PubMed ID: 15530464
    [Abstract] [Full Text] [Related]

  • 31. An automatic technique for the routine fractionation of the urinary hydroxyproline containing peptides.
    Szymanovicz A, Joubert PM, Garbe A, Randoux A, Borel JP.
    Clin Chim Acta; 1980 Jan 15; 100(2):155-64. PubMed ID: 7351087
    [Abstract] [Full Text] [Related]

  • 32. [Excretion of hydroxyproline-peptides in porcine urine as an intensity-in-dicator of bone-metabolism].
    Plonait H.
    Berl Munch Tierarztl Wochenschr; 1970 Jan 01; 83(1):11-4. PubMed ID: 5474141
    [No Abstract] [Full Text] [Related]

  • 33. On the influence of the natriuretic factor from patients with chronic uremia on the bioelectric properties and sodium transport of the isolated mammalian collecting tubule.
    Fine LG, Bourgoignie JJ, Hwang KH, Bricker NS.
    J Clin Invest; 1976 Sep 01; 58(3):590-7. PubMed ID: 956387
    [Abstract] [Full Text] [Related]

  • 34. [Modifications of peptide hydroxyprolinuria during Paget's disease and osteoma (author's transl)].
    Dakkak R, Goussault Y, Dreux C.
    Ann Biol Clin (Paris); 1979 Sep 01; 37(4):195-200. PubMed ID: 525849
    [Abstract] [Full Text] [Related]

  • 35. Peptiduria in the Fanconi syndrome.
    Asatoor AM, Milne MD, Walshe JM.
    Ciba Found Symp; 1977 Sep 01; (50):287-98. PubMed ID: 244388
    [Abstract] [Full Text] [Related]

  • 36. Multiple immunoreactive forms of osteocalcin in uremic serum.
    Gundberg CM, Weinstein RS.
    J Clin Invest; 1986 Jun 01; 77(6):1762-7. PubMed ID: 3486885
    [Abstract] [Full Text] [Related]

  • 37. The use of hydroxy-DL-proline-2-(14)C in the investigation of hydroxyproline metabolism in normal subjects and in patients with renal insufficiency.
    Hart W, van den Hamer CJ, van der Sluys Veer J.
    Clin Nephrol; 1976 Sep 01; 6(3):379-87. PubMed ID: 991465
    [Abstract] [Full Text] [Related]

  • 38. Experimental renal osteodystrophy. The response to 25-hydroxycholecalciferol and dicholomethylene diphosphate therapy.
    Russell JE, Termine JD, Avioli LV.
    J Clin Invest; 1975 Sep 01; 56(3):548-54. PubMed ID: 1159072
    [Abstract] [Full Text] [Related]

  • 39. ["The middle molecules" are uremic toxins (author's transl)].
    Hanicki Z, Cichocki T.
    Przegl Lek; 1978 Sep 01; 35(2):301-5. PubMed ID: 652997
    [No Abstract] [Full Text] [Related]

  • 40. Hydroxyproline peptides of urine in fluorosis.
    Anasuya A, Rao BS.
    Clin Chim Acta; 1974 Oct 15; 56(1):121-3. PubMed ID: 4423286
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.